Percutaneous Left Atrial Appendage Occlusion for Stroke Prophylaxis in Nonvalvular Atrial Fibrillation A Systematic Review and Analysis of Observational Studies

被引:69
作者
Bajaj, Navkaranbir Singh [1 ]
Parashar, Akhil [2 ]
Agarwal, Shikhar [2 ]
Sodhi, Nishtha [3 ]
Poddar, Kanhaiya Lal [2 ]
Garg, Aatish [3 ]
Tuzcu, E. Murat [2 ]
Kapadia, Samir R. [2 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Internal Med, Cleveland, OH 44195 USA
关键词
closure devices; left atrial appendage occlusion; nonvalvular atrial fibrillation; stroke; systematic analysis; HIGH-RISK PATIENTS; TRANSCATHETER OCCLUSION; PREVENTION; CLOSURE; WARFARIN; ANTICOAGULATION; PLAATO; FEASIBILITY; EXPERIENCE; DEVICE;
D O I
10.1016/j.jcin.2013.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The goal of this study was to provide a systematic review and analysis of observational studies on percutaneous left atrial appendage (LAA) occlusion for stroke prophylaxis in nonvalvular atrial fibrillation (NVAF). Background A recent randomized controlled trial in patients with NVAF suggested noninferiority of percutaneous LAA occlusion versus medical management for stroke prevention. However, the use of percutaneous devices remains controversial because of limited literature on their efficacy and safety. We performed a systematic analytical review of existing observational studies to assess the rate of neurological events for patients treated with occlusion devices. Methods A comprehensive search of the Medline, Scopus, and Web of Science databases from inception through August 1, 2013, was conducted using pre-defined criteria. We included studies reporting implantation in at least 10 patients and a follow-up of 6 months or more. Results In 17 eligible studies, a total of 1,052 devices were implanted in 1,107 patients with 1,586.4 person-years (PY) of follow-up. The adjusted incidence rate of stroke was 0.7/100 PY (95% confidence interval [CI]: 0.3 to 1.1/100 PY), of transient ischemic attacks was 0.5/100 PY (95% CI: 0.1 to 1.8/100 PY), and of combined neurological events (strokes or transient ischemic attacks) was 1.1/100 PY (95% CI: 0.6 to 1.6/100 PY). Access site vascular complications and pericardial effusion were the most commonly observed procedural complications at a rate of 8.6% (95% CI: 6.3% to 11.7%) and 4.3% (95% CI: 3.1% to 5.9%), respectively. Conclusions Our systematic review suggested comparable efficacy of LAA occlusion devices compared with historical controls treated with adjusted-dose warfarin and other anticoagulation strategies for prevention of stroke in patients with NVAF. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:296 / 304
页数:9
相关论文
共 37 条
[1]   Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism [J].
Agarwal, Shikhar ;
Bajaj, Navkaranbir Singh ;
Kumbhani, Dharam J. ;
Tuzcu, E. Murat ;
Kapadia, Samir R. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) :777-789
[2]   Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation A Meta-analysis [J].
Agarwal, Shikhar ;
Hachamovitch, Rory ;
Menon, Venu .
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (08) :623-631
[3]  
[Anonymous], PREVAIL STUD PROSP R
[4]   Intraprocedural and Long-Term Incomplete Occlusion of the Left Atrial Appendage Following Placement of the WATCHMAN Device: A Single Center Experience [J].
Bai, Rong ;
Horton, Rodney P. ;
Di Biase, Luigi ;
Mohanty, Prasant ;
Pump, Agnes ;
Cardinal, Deb ;
Scallon, Chantel ;
Mohanty, Sanghamitra ;
Santangeli, Pasquale ;
Brantes, Mauricio C. ;
Sanchez, Javier ;
Burkhardt, J. David ;
Zagrodzky, Jason D. ;
Gallinghouse, G. Joseph ;
Natale, Andrea .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (05) :455-461
[5]   Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation Initial Clinical Experience [J].
Bartus, Krzysztof ;
Han, Frederick T. ;
Bednarek, Jacek ;
Myc, Jacek ;
Kapelak, Boguslaw ;
Sadowski, Jerzy ;
Lelakowski, Jacek ;
Bartus, Stanislaw ;
Yakubov, Steven J. ;
Lee, Randall J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (02) :108-118
[6]  
Bayard YL, 2010, EUROINTERVENTION, V6, P220, DOI 10.4244/
[7]   Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation [J].
Blackshear, JL ;
Odell, JA .
ANNALS OF THORACIC SURGERY, 1996, 61 (02) :755-759
[8]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[9]   Does Left Atrial Appendage Closure with a Cardiac Plug System Reduce the Stroke Risk in Nonvalvular Atrial Fibrillation Patients? A Single-Center Case Series [J].
Danna, Paolo ;
Proietti, Riccardo ;
Sagone, Antonio ;
Arensi, Andrea ;
Viecca, Maurizio ;
Rago, Anna ;
Russo, Vincenzo .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (03) :347-353
[10]   Prevention of stroke by percutaneous left atrial appendage closure: Short term follow-up [J].
De Meester, Pieter ;
Thijs, Vincent ;
Van Deyk, Kristien ;
Budts, Werner .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 142 (02) :195-196